Etravirine

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 816 publications

Repurposing Etravirine as a PlcA-Targeting inhibitor to block autophagic escape of Listeria monocytogenes.

Repurposing Etravirine as a PlcA-Targeting inhibitor to block autophagic escape of Listeria monocytogenes.

Journal: Autophagy

Published: October 29, 2026

Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment.

Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: September 08, 2026

Targeting the HIV-1 NNRTI Entrance Channel: Structure-Guided Optimization for Enhanced Safety and Selectivity.

Targeting the HIV-1 NNRTI Entrance Channel: Structure-Guided Optimization for Enhanced Safety and Selectivity.

Journal: Journal of medicinal chemistry

Published: July 23, 2026

Integrated analysis of HIV-1 drug resistance across reverse transcriptase, protease and integrase in india: gene-region-corrected prevalence and threshold-specific scoring from public sequence data.

Integrated analysis of HIV-1 drug resistance across reverse transcriptase, protease and integrase in india: gene-region-corrected prevalence and threshold-specific scoring from public sequence data.

Journal: Infection

Published: July 12, 2026

Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study.

Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study.

Journal: The Journal of antimicrobial chemotherapy

Published: May 15, 2026

Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells.

Repurposing Antiretroviral Drugs for Urological Cancers: Differential Effects of Protease Inhibitors and NNRTIs on Prostate and Bladder Cancer Cells.

Journal: Cells

Published: April 25, 2026

Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios.

Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios.

Journal: Viruses

Published: April 23, 2026

Deep learning-based prediction of drug-target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach.

Deep learning-based prediction of drug-target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach.

Journal: Computational biology and chemistry

Published: April 21, 2026

Drug Resistance in HIV Following First-line ART Failure: Insights from a Cross-sectional Study in India.

Drug Resistance in HIV Following First-line ART Failure: Insights from a Cross-sectional Study in India.

Journal: The Journal of the Association of Physicians of India

Published: March 12, 2026

Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens.

Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens.

Journal: Pharmaceutics

Published: March 02, 2026

Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China

Drug resistance characteristics of rilpivirine in HIV-1-infected patients before starting antiretroviral therapy in nine provinces of China

Journal: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi

Published: March 01, 2026

Budget impact analysis of medication reviews by junior pharmacists in polypharmacy patients: a hospital perspective.

Budget impact analysis of medication reviews by junior pharmacists in polypharmacy patients: a hospital perspective.

Journal: International journal of clinical pharmacy

Published: February 11, 2026

Showing 1-12 of 816

Last Updated: 11/08/2026